Literature DB >> 7962481

Migration of activated lymphocytes when adoptively transferred into cannulated rat brain.

C A Kruse1, Q Kong, P M Schiltz, B K Kleinschmidt-DeMasters.   

Abstract

Migration of fluorescent DNA-labeled or 111Indium-labeled activated lymphocytes was studied in normal rat brain bearing surgically implanted cannulas. The migration of allogeneic cytotoxic T lymphocytes (CTL), derived from the DA rat (DA anti Fischer CTL), and of syngeneic concanavalin A (ConA)-activated lymphocytes (Fischer Con A blasts), was determined in Fischer rats between 2 h and 7 days post instillation into parietal brain. Whole body nuclear imaging indicated that the majority of the radiolabeled lymphocytes, either syngeneic or allogeneic, were present in the brain at 2 and 18 h. Autoradiography of brain slices demonstrated that label was located throughout the brain and in both hemispheres at all time points. By direct tissue radioassay, approximately 60% of the injected dose was present between 2 and 18 h; this decreased to 18% by day 7. By fluorescence microscopy, large numbers of lymphocytes were visible up to 3-4 days. The lymphocytes traveled from the instillation site into both cerebral hemispheres primarily following white matter tracts. Preferential localization of fluorescently labeled lymphocytes was seen in the corpus callosum, internal and external capsules, anterior commissures, lateral olfactory tracts, white matter connections in the caudate and putamen, mammillothalamic and optic tracts. Overall, gray matter contained fewer cells although perivascular spaces within it had high concentrations of cells, indicating these spaces may act as points of egress.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7962481     DOI: 10.1016/0165-5728(94)90142-2

Source DB:  PubMed          Journal:  J Neuroimmunol        ISSN: 0165-5728            Impact factor:   3.478


  6 in total

1.  Implementing preclinical study findings to protocol design: translational studies with alloreactive CTL for gliomas.

Authors:  Michelle J Hickey; Colin C Malone; Kate E Erickson; German G Gomez; Emma L Young; Linda M Liau; Robert M Prins; Carol A Kruse
Journal:  Am J Transl Res       Date:  2012-01-10       Impact factor: 4.060

Review 2.  Rat brain tumor models in experimental neuro-oncology: the 9L, C6, T9, F98, RG2 (D74), RT-2 and CNS-1 gliomas.

Authors:  R F Barth
Journal:  J Neurooncol       Date:  1998-01       Impact factor: 4.130

3.  Catalytic nucleic acid enzymes for the study and development of therapies in the central nervous system: Review Article.

Authors:  Richard Tritz; Cellia Habita; Joan M Robbins; German G Gomez; Carol A Kruse
Journal:  Gene Ther Mol Biol       Date:  2005

4.  Distribution of adoptively transferred, tumor-sensitized lymphocytes in the glioma-bearing rat.

Authors:  Monica R Hazelrigg; Jerry I Hirsch; Randall E Merchant
Journal:  J Neurooncol       Date:  2002-11       Impact factor: 4.130

5.  Brain CD8+ and cytotoxic T lymphocytes are associated with, and may be specific for, human immunodeficiency virus type 1 encephalitis in patients with acquired immunodeficiency syndrome.

Authors:  Carol K Petito; Jorge E Torres-Muñoz; Fabiana Zielger; Micheline McCarthy
Journal:  J Neurovirol       Date:  2006-08       Impact factor: 3.739

Review 6.  Immunological considerations of modern animal models of malignant primary brain tumors.

Authors:  Michael E Sughrue; Isaac Yang; Ari J Kane; Martin J Rutkowski; Shanna Fang; C David James; Andrew T Parsa
Journal:  J Transl Med       Date:  2009-10-08       Impact factor: 5.531

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.